BankUnited, Inc. (BKU)
NYSEFinancialsBanks - RegionalSnapshot 2026-11-05
$44.54-0.93%
Close 2026-11-05 · 1-day change
NYSEFinancialsBanks - RegionalSnapshot 2026-11-05
Research Workspace
Put BKU beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Regional Banks is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue grows to at least $1.17 billion in FY26: Comparison needs review.
View ThesisRevenue is contracting — down about 5% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskBKU's commercial loan growth must keep compounding to justify the price. Revenue grew 2% in the latest quarter. The company missed its earnings target by 1.9%. It trades at 1.1 times book value. Peers trade at a 1.2 times median. The market is pricing in more growth than we forecast. Reserve coverage sits below 100% of nonperforming loans. The thesis comparison is not yet verified. Peer multiples imply a price about 5% above where it trades. The thesis is on watch. This read is provisional.
Trailing returns as of 2026-11-05. BKU is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering BKU (as of Nov 2026).
Based on 6 Wall Street analysts offering 12-month price targets for BKU in the last 4 months.
Continue this research
Compare BKU with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BKU Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 6 valuation methods, at three horizons. As of 2026-11-05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Regional Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put BKU next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Maintain strong credit quality and allowance coverage
Q3 results are solid, but reserve concerns add a meaningful credit-quality headwind.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-05. EPS is implied from price ÷ P/E. Not investment advice.
Current $44.54
The last 12 months of price, then the range of analyst 12-month targets from today’s $44.54.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Increase profitability and revenue growth
Margin expansion and deposit growth support profitability and funding objectives.
Threatens: Increase revenue growth
Rising rates may hinder revenue growth in Q3.
Advances: Grow core commercial loans and shift loan portfolio mix
New leadership supports growth in commercial loans.
Threatens: Increase profitability and revenue growth
Downgrade cites weaker 2027 EPS visibility, raising concerns about future profitability.
Advances: Increase revenue growth
New hire supports revenue growth strategy.
Advances: Maintain strong credit quality and allowance coverage
Earnings beat with lower provisions supports credit normalization and stronger profitability.
